Trovagene Q2 Revenues Improve 14 Percent, Loss Narrows | GenomeWeb

NEW YORK (GenomeWeb) – Trovagene said after the close of the market on Thursday that its second quarter revenues were up 14 percent year over year as it sharply narrowed its losses.

The San Diego firm posted $56,000 in revenues for the three months ended June 30, up from $49,000 in the year-ago quarter ago.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.